Global Newcastle Disease Vaccine Market Insights: Impact of COVID-19 and Future Expectations to 2025

The Newcastle Disease Vaccine market revenue was 288 Million USD in 2019, and will reach 349 Million USD in 2025, with a CAGR of 3.24% during 2020-2025. Newcastle disease is a viral disease caused by avian paramyxovirus type 1 (APMV-1). The roots of this virus can be traced back to the genus Avulavirus, belonging to the Paramyxoviridae family. Newcastle disease virus (NDV) is a contagious bird disease, which affects various domestic birds such as chicken and turkey, among other birds. Chicken is found to be more susceptible to this disease. The viral strain can be classified into various phenotypes depending upon the virulence expression in chicken. These include the least virulent strains, moderately virulent strains, which are also called mesogenic strains, and the most virulent strains also known as velogenic strains. The disease is transmitted by the fecal-oral route, owing to the exposure to the infected birds’ excretion, contaminated food, water, and equipment, among others. This disease is transmittable to humans.
This report elaborates the market size, market characteristics, and market growth of the Newcastle Disease Vaccine industry, and breaks down according to the type, application, and consumption area of Newcastle Disease Vaccine. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.

In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Newcastle Disease Vaccine in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.

Key players in the global Newcastle Disease Vaccine market covered in Chapter 11:
FATRO
Merck Animal Health
Vaksindo
Kyoto Biken
Yebio
HVRI
CAVAC
Merial
ChengDu Tecbond
Sindh Poultry Vaccine Centre
CEVA
DHN
QYH Biotech
Elanco
Ringpu Biology
Zoetis

In Chapter 3, on the basis of types, the Newcastle Disease Vaccine market from 2015 to 2025 is primarily split into:
Live Vaccines
Killed Vaccines

In Chapter 4, on the basis of applications, the Newcastle Disease Vaccine market from 2015 to 2025 covers:
Chicken
Duck & Goose
Other

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:
North America (Covered in Chapter 6)
United States
Canada
Mexico
Europe (Covered in Chapter 7)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8)
China
Japan
South Korea
Australia
India
Middle East and Africa (Covered in Chapter 9)
Saudi Arabia
UAE
Egypt
South Africa
South America (Covered in Chapter 10)
Brazil
Argentina
Columbia

Years considered for this report:

Historical Years:

2015-2019

Base Year:

2019

Estimated Year:

2020

Forecast Period:

2020-2025